Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis

Archives of Neurology

Volumn 54, Issue 8, 1997, Pages 1018-1025

  Hohol, Marika J ^a,c   Guttmann, Charles R G ^a   Orav, John ^b   Mackin, Glenn A ^a,d   Kikinis, Ronald ^a   Khoury, Samia J ^a   Jolesz, Ferenc A ^a   Weiner, Howard L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITIVE DEFECT; FEMALE; HUMAN; MALE; MEMORY; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0030757343     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550200074013     Document Type: Article

References (42)

1. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis, I: frequency, patterns and prediction. Neurology. 1991;41:685-691.
2. Rao SM. Neuropsychology of multiple sclerosis: a critical review. J Clin Exp Neuropsychol. 1986;8:503-542.
3. Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology. 1989;39:161-166.
4. Swirsky-Sacchetti T, Mitchell DR, Seward J, et al. Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis. Neurology. 1992;42:1291-1295.
5. Clark CM, James G, Li D, Oger J, Paty D, Klonoff H. Ventricular size, cognitive function and depression in patients with multiple sclerosis. Can J Neurol Sci. 1992;19:352-356.
6. Huber SJ, Paulson GW, Shuttleworth EC, et al. Magnetic resonance imaging correlates of dementia in multiple sclerosis. Arch Neurol. 1987;44:732-736.
7. Comi G, Filippi M, Martinelli V, et al. Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis. J Neurol Sci. 1993;115(suppl):S66-S73.
8. Medaer R, Nelissen E, Appel B, Swerts M, Geutjens J, Callaert H. Magnetic resonance imaging and cognitive functioning in multiple sclerosis. J Neurol. 1987;235:86-89.
9. Pozzilli C, Passafiume D, Bernardi S, et al. SPECT, MRI and cognitive functions in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1991;54:110-115.
10. Reischies FM, Baum K, Brau H, Hedde JP, Schwindt G. Cerebral magnetic resonance imaging findings in multiple sclerosis: relation to disturbance of affect, drive, and cognition. Arch Neurol. 1988;45:1114-1116.
11. Franklin GM, Heaton RK, Nelson LM, Filley CM, Seibert C. Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis. Neurology. 1988;38:1826-1829.
12. Feinstein A, Ron M, Thompson A. A serial study of psychometric and magnetic resonance imaging changes in multiple sclerosis. Brain. 1993;116:569-602.
13. Mariani C, Farina E, Cappa SF, et al. Neuropsychological assessment in multiple sclerosis: a follow-up study with magnetic resonance imaging. J Neurol. 1991;238:395-400.
14. Mattioli F, Cappa SF, Cominelli C, Capra R, Marcianoc N, Gasparotti R. Serial study of neuropsychological performance and gadolinium-enhanced MRI in MS. Acta Neurol Scand. 1993;87:465-468.
15. Goodkin DE, Ross JS, Medendorp SV, Konecsni J, Rudick RA. Magnetic resonance imaging lesion enlargement in multiple sclerosis: disease-related activity, chance occurrence, or measurement artifact? Arch Neurol. 1992;49:261-263.
16. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-231.
17. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983;33:1444-1452.
18. Hauser SL, Dawson DM, Lehrich JR, et al. Intensive immunosuppression in progressive multiple sclerosis: a randomized, three-arm study of high dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med. 1983;308:173-180.
19. Rao SM, Cognitive Function Study Group, National Multiple Sclerosis Society. A Manual for the Brief, Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. New York, NY: National Multiple Sclerosis Society; 1990.
20. Bever CT, Grattan L, Panitch HS, Johnson KP. The Brief, Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study. Mult Scler. 1995;1:165-169.
21. Kikinis R, Shenton ME, Gerig G, et al. Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging. J Magn Reson Imaging. 1992;2:619-629.
22. Ettinger GJ, Grimson WEL, Lozano-Perez T, Wells WM III, White SJ, Kikinis R. Automatic registration for multiple sclerosis change detection. In: Proceedings of the Institute of Electrical and Electronics Engineers Inc Workshop on Biomedical Image Analysis. Los Alamitos, Calif: IEEE Computer Society Press; 1994:297-306.
23. Wells WM III, Grimson WEL, Kikinis R, Jolesz FA. Adaptive segmentation of MRI data. IEEE Trans Med Imag. 1996;15:429-442.
24. Metcalf D, Kikinis R, Guttmann CRG, Vaina L, Jolesz F. 4D connected component labeling applied to quantitative analysis of MS lesion temporal development. In: Proceeding of the 14th Annual International Conference of the IEEE-EMBS. Piscataway, NJ: IEEE Service Center; 1992;14:945-946.
25. Rao SM, Reingold SC, Ron MA, Lyon-Caen O, Comi G. Workshop on neurobehavioral disorders in multiple sclerosis. Arch Neurol. 1993;50:658-662.
26. Jennekens-Schinkel A, Laboyrie PM, Lanser JBK, van der Velde EA. Cognition in patients with multiple sclerosis after four years. J Neurol Sci. 1990;99:229-247.
27. Ivnik RJ. Neuropsychological stability in multiple sclerosis. J Consult Clin Psychol. 1978;46:913-923.
28. Canter AH. Direct and indirect measures of psychological deficit in multiple sclerosis. J Gen Psychol. 1951;44:3-50.
29. Fink SL, Houser HB. An investigation of physical and intellectual changes in multiple sclerosis. Arch Phys Med Rehabil. 1966;47:56-61.
30. Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, Amaducci L. Cognitive impairment in early-onset multiple sclerosis: pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol. 1995;52:168-172.
31. Feinstein A, Kartsounis LD, Miller DH, Youl BD, Ron MA. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study. J Neurol Neurosurg Psychiatry. 1992;55:869-876.
32. Filley CM, Heaton RK, Thompson LL, Nelson LM, Franklin GM. Effects of disease course on neuropsychological functioning. In: Rao SM, ed. Neurobehavioral Aspects of Multiple Sclerosis. New York, NY: Oxford University Press Inc; 1990:136-148.
33. Goodkin DE, Rudick RA, Ross JS. The use of brain magnetic resonance imaging in multiple sclerosis. Arch Neurol. 1994;51:505-516.
34. Callanan MM, Logsdail SJ, Ron MA, Warrington EK. Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis: a psychometric and MRI study. Brain. 1989;112:361-374.
35. Filley CM, Heaton RK, Nelson LM, Burks JS, Franklin GM. A comparison of dementia in Alzheimer's disease and multiple sclerosis. Arch Neurol. 1939;46:157-161.
36. Heaton RK, Nelson LM, Thompson DS, Burks JS, Franklin GM. Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol. 1985;53:103-110.
37. Möller A, Wiedemann G, Rohde U, Backmund H, Sonntag A. Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatr Scand. 1994;89:117-121.
38. Rao SM, Hammeke TA, Speech TJ. Wisconsin Card Sorting Test performance in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol. 1987;55:263-265.
39. Gonzalez CF, Swirsky-Sacchetti T, Mitchell D, Lublin FD, Knobler RL, Ehrlich SM. Distributional patterns of multiple sclerosis brain lesions: magnetic resonance imaging-clinical correlation. J Neuroimag. 1994;4:188-195.
40. Koopmans RA, Li DKB, Grochowski EW, Cutler PJ, Paty DW. Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features. Ann Neurol. 1989;25:74-81.
41. The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis, I: clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology. 1993;43:655-661.
42. Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular Interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol. 1996;39:285-294.